21256 ⎘
Medicinal preparations containing active ingredients not provided for in groups - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
FORMULATION FOR WOUND HEALING
#6602RATIONALE, DESIGN, SYNTHESIS AND VALIDATION OF A SMALL MOLECULE ANTICANCER AGENT
#66035ALPHA-HYDROXY-6BETA-[2-(1-H-IMIDAZOL-4-YL)-ETHYLAMINO]-CHOLESTAN-3BETA-OL ANALOGUES AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME FOR USE IN THE TREATMENT OF CANCER
#6604HYDROPHOBIC COMPOSITIONS INCLUDING A HYDROPHILIC ACTIVE INGREDIENT AND METHODS RELATING THERETO
#6605INDOLIN-2-ONE OR PYRROLO -PYRIDIN -2 -ONE DERIVATIVES
#6606Novel Compounds
#6607IMIDAZOPYRIDINE DERIVATIVES AND AZA-IMIDAZOPYRIDINE DERIVATIVES AS JANUS KINASE 2 INHIBITORS AND USES THEREOF
#66081-(2-(4-CYCLOPROPYL-1H-1,2,3-TRIAZOL-1-YL)ACETYL)-4-HYDROXY-N-(BENZYL)PYRROLIDIN E-2-CARBOXAMIDE DERIVATIVES AS VHL INHIBITORS FOR THE TREATMENT OF ANEMIA AND CANCER
#6609HETEROCYCLIC GLP-1 AGONISTS
#6610PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AND RELATED USES
#6611CRYSTALLINE AND AMORPHOUS FORMS OF A DELTA-OPIOID MODULATOR
#6612GLP-1R MODULATING COMPOUNDS
#6613INHIBITORS OF THE BROMODOMAIN PHD FINGER TRANSCRIPTION FACTOR (BPTF) AS ANTI-CANCER AGENTS
#6614THERAPEUTIC COMPOSITIONS FOR ENHANCED HEALING OF WOUNDS AND SCARS
#6615COMPOSITIONS FOR INDUCING TUMOR IMMUNITY AND REDUCING DRUG TOLERANCE
#6616COMPOUNDS AND COMPOSITIONS FOR IMMUNOTHERAPY
#6617COMPOSITION CONTAINING 5-AMINOLEVULINIC ACID HYDROCHLORIDE
#6618Treatment of Cancer with Naltrexone
#6619AUTOLOGOUS AND ALLOGENIC HIV-1 PROTEINS FOR THE TREATMENT OF LATENT HIV-1 INFECTION
#6620GENETIC APPROACH TO SUPPRESS CORONAVIRUSES
#6621PARAPHARMACEUTICAL OR PHARMACEUTICAL COMPOSITION ADMINISTRABLE TO A LIVING BEING, PREFERABLY A HUMAN BEING, COMPRISING AT LEAST ONE ENZYME FOR THE TREATMENT AND/OR PREVENTION OF BACTERIAL INFECTIONS INVOLVING BIOFILM FORMATION
#6622ISCHEMIA/REPERFUSION INJURY
#6623APPLICATION OF PREVOTELLA STERCOREA STRAIN FOR CANCER PREVENTION OR TREATMENT
#6624TREATMENT OF RADICULAR PAIN WITH CELL-FREE AMNIOTIC FLUID
#6625METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENT OF GRAFT VERSUS HOST DISEASE
#6626METHOD OF TREATMENT OF CANCER OR TUMOUR
#6627COMPOSITIONS OF NITRATES AND METHODS OF USE THEREOF
#6628METHODS OF PREVENTING HIV INFECTIONS IN HUMANS
#6629NOVEL THERAPEUTIC COMBINATIONS COMPRISING DERIVATIVES OF OXAZAPHOSPHORINES FOR THE TREATMENT OF CANCER
#6630PHARMACEUTICAL COMPOSITIONS OF IBRUTINIB
#6631METHODS TO SENSITIZE TUMORS TO TREATMENT BY IMMUNOTHERAPY
#6632TREATMENT OF AUTOIMMUNE DISEASES WITH A DIHYDROOROTATE HEHYDROGENASE (DHODH) INHIBITOR
#6633METHODS FOR TREATING REMITTING MULTIPLE SCLEROSIS
#6634APPLICATION OF RILUZOLE IN TREATMENT OF OLIGOSPERMIA
#6635METHODS OF TREATING RIBONUCLEOTIDE REDUCTASE-RELATED DISEASES WITH A RIBONUCLEOTIDE REDUCTASE INHIBITOR
#6636MODULATION OF GLUCAGON-LIKE PEPTIDE 1 AND USES THEREOF
#6637COMPOSITION FOR ENHANCING TUMOR PENETRATION OF ANTICANCER DRUG, COMPRISING LOSARTAN AS ACTIVE INGREDIENT, AND USE THEREOF
#6638DASH INHIBITORS, AND USES RELATED THERETO
#6639ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS
#6640COMPOSITIONS AND METHODS FOR TREATING REPERFUSION INJURY OR HEMORRHAGE AFTER RECANALIZATION THERAPY
#6641METHODS OF TREATING DISEASE WITH DICHLORPHENAMIDE
#6642SNAP-FIT LOCKING MECHANISM FOR A WATER FILTER CARTRIDGE COVER IN A HOUSEHOLD APPLIANCE, METHOD FOR LOCKING THE CARTRIDGE COVER AND HOUSEHOLD APPLIANCE
#6643Transdermal psychoactive alkaloid composition and preparation thereof
#6644PHARMACEUTICAL COMPOSITION AND METHOD FOR ENHANCING SOLUBILITY OF POORLY SOLUBLE ACTIVE PHARMACEUTICAL INGREDIENTS
#6645METHODS FOR PRODUCTION OF MSC-DERIVED EXOSOMES
#6646SELF-REGULATING BIOADHESIVES FOR WET SUBSTRATES
#6647OCULAR IMPLANT CONTAINING AN ACTIVE INGREDIENT
#6648System and method for inventory planning in a supply chain network
#6649NOVEL BIOMARKER OF ACUTE CORONARY SYNDROMES
#6650BIOMARKERS FOR PREDICTING RESPONSIVENESS TO MEK INHIBITOR MONOTHERAPY AND COMBINATION THERAPY
#6651METHODS FOR TREATMENT OF LUNG CANCERS
#6652METHODS AND COMPOSITIONS FOR PREVENTING OR DELAYING TYPE 1 DIABETES
#6653MEANS AND METHODS FOR TREATING AND DIAGNOSING FIBROSIS OR FIBROSIS-ASSOCIATED DISEASES
#6654Nanoparticles having molecules that bind or block PD-L1 and uses in treating cancer
#6655Crystalline forms of a CD73 inhibitor and uses thereof
#6656DIOXOLANE ANALOGUES OF URIDINE FOR THE TREATMENT OF CANCER
#6657COMPOUNDS AND USES THEREOF
#6658MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
#6659SHMT Inhibitors
#6660Substituted piperazines as BTK inhibitors
#6661GCN2 AND PERK KINASE INHIBITORS AND METHODS OF USE THEREOF
#6662SMALL MOLECULE MODULATORS OF GP130 SIGNALING PATHWAYS, TOPICAL FORMULATIONS AND METHOD OF USE THEREOF
#6663Chemical compounds
#6664Gamma-hydroxybutyrate delivering compounds and processes for making and using them
#6665SUBSTITUTED BISPHENYLALKYLUREA COMPOUNDS AND METHODS OF TREATING INFLAMMATORY CONDITIONS
#6666PROCESSES FOR SYNTHESIS OF ALPHA-EMITTING RADIOPHARMACEUTICALS
#6667POLYGLUTAMATED ANTIFOLATES AND USES THEREOF
#6668MIR-145 MICELLES FOR MITIGATING ATHEROSCLEROSIS
#6669SMALL MOLECULE DRUG CONJUGATES
#6670TREATMENT OF AUTISM SPECTRUM DISORDER AND ASSOCIATED SYMPTOMS
#6671USES OF PTHrP ANALOGUE IN REDUCING FRACTURE RISK
#6672Methods and compositions for preventing or treating ophthalmic conditions
#6673MICROBIAL-BASED COMPOSITIONS FOR SYSTEMIC INFLAMMATION CONTROL
#6674Vaginal care compositions and methods of improving vaginal health
#6675METHODS AND COMPOSITIONS FOR CELLULAR IMMUNOTHERAPY
#6676COMPOSITIONS FOR CANCER TREATMENT AND METHODS AND USES FOR CANCER TREATMENT AND PROGNOSIS
#6677NOVEL COMBINATION TREATMENT FOR ACUTE MYELOID LEUKEMIA (AML)
#6678MARIBAVIR ISOMERS, COMPOSITIONS, METHODS OF MAKING AND METHODS OF USING
#6679METHODS AND COMPOSITIONS FOR TREATING FIBROTIC DISEASES
#6680METHODS AND COMPOSITIONS FOR THE TREATMENT OF TRAUMATIC BRAIN INJURY (TBI) AND RELATED DISORDERS
#6681TRANSIENT PROTECTION OF NORMAL CELLS DURING CHEMOTHERAPY
#6682Medical Use of Pharmaceutical Combination or Composition
#6683Therapeutic agent composition and method of use, for treatment of mild congnitive impairment, depression, and psychological disorders
#6684COMBINATIONS OF BCL-2 INHIBITORS WITH CHEMOTHERAPEUTIC AGENTS
#6685ADJUNCTIVE THERAPY FOR DEPRESSION
#6686DABIGATRAN COMPOSITIONS AND METHODS OF TREATING AGE-RELATED MACULAR DEGENERATION
#6687METHODS FOR TREATING COLON CANCER WITH COMPOSITIONS COMPRISING AMLEXANOX AND IMMUNE CHECKPOINT INHIBITORS
#6688RILUZOLE PRODRUGS AND THEIR USE
#6689Riluzole prodrugs and their use
#6690Substituted benzothiophene analogs as selective estrogen receptor degraders
#6691NOVEL COMPOUNDS
#6692FORMULATIONS CONTAINING OMEGA-3 FATTY ACIDS OR ESTERS THEREOF AND MAQUI BERRY EXTRACT AND THERAPEUTIC USES THEREOF
#6693COMPOSITIONS AND METHODS FOR AMELIORATING MEDICAL CONDITIONS
#6694METHOD OF TREATING POST-TRAUMATIC STRESS DISORDER
#6695Close-packed fibrous dosage form
#6696METHOD AND SYSTEM FOR ADVANCED TECHNOLOGY PACKAGING AND DELIVERY OF ACTIVE CHEMICAL INGREDIENTS
#6697RINSE-OFF COMPOSITIONS AND USES THEREOF FOR DELIVERY OF ACTIVE AGENTS
#6698GEL BASE COMPOSITION FOR COMPOUNDING INTO A MUCOADHESIVE DELIVERY SYSTEM
#6699METHODS AND COMPOSITIONS FOR TREATING CANCER WITH ECM-AFFINITY PEPTIDES LINKED TO IMMUNOTHERAPEUTIC ANTIBODIES
#6700METHODS FOR IDENTIFICATION, STRATIFICATION, AND TREATMENT OF CNS DISEASES
#6701Markers selectively deregulated in tumor-infiltrating regulatory T cells
#6702METHODS AND AGENTS FOR TREATING, PREVENTING, DIAGNOSING, AND EVALUATING THERAPY FOR FIBROTIC, AUTOIMMUNE, AND INFLAMMATORY CONDITIONS
#6703COMBINATION
#6704COMBINATION THERAPY FOR ALPORT RENAL DISEASE
#6705COMPOSITIONS FOR TREATMENT ALOPECIA AREATA, BIOMARKERS FOR TREATMENT SUCCESS AND, METHODS OF USE THEREOF
#6706FERRITIN NANOCAGE FUSED WITH PD-L1-BINDING PEPTIDE 1 AND USE THEREOF AS ANTICANCER IMMUNOTHERAPY AGENT
#6707CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD19 CHIMERIC ANTIGEN RECEPTOR (CAR)-EXPRESSING CELL
#6708CD206 targeted drug delivery vehicles carrying novel bisphosphonate drug payloads via a degradable linker
#6709MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
#6710BICYCLIC COMPOUNDS
#6711LACTIVICIN COMPOUNDS, THEIR PREPARATION AND USE AS ANTIBACTERIAL AGENTS
#6712Compositions And Methods For Treating Attention Deficit Disorders
#6713MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
#6714MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
#6715MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
#6716TETRAHYDRO-1H-CYCLOPENTA[CD]INDENE DERIVATIVES AS HYPOXIA INDUCIBLE FACTOR-2(ALPHA) INHIBITORS
#6717Anesthetic compounds and methods of making and using same to treat or prevent pain symptoms
#6718SYNTHETIC NANOCARRIERS COMPRISING AN IMMUNOSUPPRESSANT IN COMBINATION WITH HIGH AFFINITY IL-2 RECEPTOR AGONISTS AND ANTI-IGM AGENTS
#6719ENHANCED DELIVERY VEHICLE FOR A TREATING AGENT
#6720DENDRIMER COMPOSITIONS AND METHODS FOR DRUG DELIVERY
#6721Formulated and/or co-formulated liposome compositions containing toll-like receptor(“TLR”) agonist prodrugs useful in the treatment of cancer and methods thereof
#6722NANOPARTICLE FOR ANTI-CANCER PEPTIDES AND USES THEREOF
#6723IMMATURE POMEGRANATE EXTRACT FORMULATIONS
#6724Oral composition comprising lactic acid bacteria for regulating immune responses and methods related thereto
#6725PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ATOPIC DISEASE CONTAINING FAECALIBACTERIUM PRAUSNITZII STRAIN
#6726METHODS FOR MODULATING TLR4 SIGNALING
#6727CELL THERAPY COMPOSITIONS AND METHODS OF USE THEREOF
#6728METHODS FOR X CHROMOSOME REACTIVATION
#6729USE OF ADENOSINE DIPHOSPHATE RIBOSE FOR ADJUVANT THERAPY WITH RADIATION AND/OR ANTI-CANCER TREATMENT
#6730COMPOSITIONS AND METHODS FOR TREATING AND AMELIORATING RESPIRATORY CONDITIONS AND INFLAMMATION OF MUCOSA
#6731COMBINATION THERAPIES USING CASPASE-1 DEPENDENT ANTICANCER AGENTS AND PGE2 ANTAGONISTS
#6732USE OF CANNABINOIDS IN THE TREATMENT OF COVID-19
#6733METHODS OF TREATING FIBROMYALGIA WITH NEUROACTIVE STEROIDS
#6734METHODS FOR TREATING LUNG INFECTIONS AND INFLAMMATION
#6735INDUCTION OF IMMUNE TOLERANCE BY USING METHOTREXATE
#6736Methods of treating cholangiocarcinoma
#6737TREATMENT OF COGNITIVE IMPAIRMENT WITH A CNS-PENETRANT sGC STIMULATOR
#6738Combination Treatment of Cancer
#6739Methods of Treating Cushing's syndrome and Liver Disorders, and of Reducing Liver Toxicity of Other Drugs Administered to a Patient
#6740COMPOUNDS AND METHODS FOR TREATING AN EPILEPTIC DISORDER
#6741Compounds useful as kinase inhibitors
#6742MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
#6743LYOPHILIZED COMPOSITION COMPRISING (S)-ISOPROPYL 2-((S)-2-ACETAMIDO-3-(1H-INDOL-3-YL)PROPANAMIDO)-6-DIAZO-5-OXOHEXANOATE FOR SUBCUTANEOUS ADMINISTRATION AND THE USE THEREOF
#6744TREATMENTS OF CORONAVIRUS INFECTIONS, CYTOKINE RELEASE SYNDROME, CYTOKINE STORM SYNDROME, OR DISEASES ASSOCIATED WITH EXCESSIVE ACTIVATION OF INFLAMMASOMES BY THE USE OF INHIBITORS OF INFLAMMATORY CASPASES
#6745FORMULATIONS COMPRISING BOTANICAL EXTRACTS
#6746ISOFLAVONOID COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER
#6747COMPOSITION COMPRISING NAPHTHOQUINONE-BASED COMPOUND AS ACTIVE INGREDIENT, FOR PREVENTING OR AMELIORATING FATIGUE, CACHEXIA, PAIN, COGNITIVE DECLINE AND HEMATOPOIETIC STEM CELL REDUCTION WHICH ARE SIDE EFFECTS RELATED TO ANTICANCER DRUG TREATMENT
#6748USE OF CYSTINE AND DERIVATIVES THEREOF AS ANTI-THROMBOTIC AND THROMBOLYTIC AGENTS
#6749Nutraceutical compositions and methods for dietary alleviation of Polycystic Ovary Syndrome
#6750FORTIFIED MICRONUTRIENT SALT FORMULATIONS
#6751Synthetic progestogens and pharmaceutical compositions comprising the same
#6752SACCHARIDE-BASED ORAL MUCOADHESIVE DELIVERY SYSTEM FOR PHARMACEUTICAL COMPOSITIONS
#6753Pharmaceutical suspension for oral dosage
#6754METHODS FOR TREATING CANCERS WITH INHIBITORS TARGETING THE ROLE OF GRB2 IN DNA REPAIR
#67555-HALOURACIL-MODIFIED MICRORNAS AND THEIR USE IN THE TREATMENT OF CANCER
#6756METHODS AND COMPOSITIONS FOR MACROPHAGE POLARIZATION
#6757Modified short interfering nucleic acid (siNA) molecules and uses thereof
#6758HYDROXYPROPYL METHYL CELLULOSE ACETATE SUCCINATE, METHOD FOR PRODUCING THE SAME, AND COMPOSITION FOR HOT-MELT EXTRUSION
#6759ANTI-CEA ANTIBODIES
#6760NUCLEIC ACIDS ENCODING HUMAN ANTIBODIES TO SIALYL-LEWIS A
#6761ANTIBODIES BINDING CD40 AND USES THEREOF
#6762METHODS OF TREATING MALIGNANT GLIOBLASTOMA
#6763ANTI-CD2 ANTIBODIES
#6764SINGLE DOMAIN ANTIBODIES AGAINST CD33
#6765NATRIURETIC PEPTIDE RECEPTOR 1 ANTIBODIES AND METHODS OF USE
#6766MEANS FOR REDUCING RADIO- AND CHEMOTHERAPY RESISTANCE AND ADVERSE EFFECTS
#6767USE OF ANTI-SCLEROSTIN ANTIBODIES IN THE TREATMENT OF OSTEOGENESIS IMPERFECTA
#6768ANTIBODY-COUPLED CYCLIC PEPTIDE TYROSINE TYROSINE COMPOUNDS AS MODULATORS OF NEUROPEPTIDE Y RECEPTORS
#6769GRIFFITHSIN FOR RHABDOVIRIDAE INFECTIONS
#6770COMPOUND FOR USE IN THE TREATMENT OF PROTOZOAL DISEASES AND PROCESS FOR PRODUCTION OF SAID COMPOUND
#6771BENZODIAZEPINE DERIVATIVES USEFUL IN TREATING A RESPIRATORY SYNCYTIAL VIRUS INFECTION
#6772HETEROCYCLIC PERICONDENSED CDC7 KINASE INHIBITORS FOR THE TREATMENT OF CANCER
#6773Photodynamic Therapy and Diagnosis
#6774IRAK degraders and uses thereof
#6775BETA-LACTAMASE INHIBITORS AND THEIR PREPARATION
#6776Compounds and uses thereof
#6777IMIDAZOPYRIDINYL COMPOUNDS AND USE THEREOF FOR TREATMENT OF NEURODEGENERATIVE DISORDERS
#6778Lithium oxyhalide electrochemical cell design for high-rate discharge
#6779N-pyridinyl acetamide derivatives as inhibitors of the Wnt signaling pathway
#6780NEW COMPOUNDS AND THEIR USE AS THERAPEUTICALLY ACTIVE SUBSTANCES IN THE TREATMENT AND/OR PREVENTION OF DISEASES INVOLVING THE RETINAL PIGMENT EPITHELIUM
#6781SMALL MOLECULE INHIBITORS OF CALCIUM CHANNEL ACTIVITY AND USES THEREOF
#6782NOVEL CHALCONE-BASED CHEMOTHERAPEUTIC COMPOUND FOR TRIPLE NEGATIVE BREAST CANCER
#6783QUINAZOLINE-2,4-DIAMINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME AS ACTIVE INGREDIENT
#6784Antiviral compounds
#67852,4,5-TRISUBSTITUTED 1,2,4-TRIAZOLONES USEFUL AS INHIBITORS OF DHODH
#6786Anesthetic compounds and methods of making and using same to treat or prevent pain symptoms
#6787METHOD FOR INHIBITING OR DISRUPTING BIOFILM FORMATION, OR REDUCING BIOFILM
#6788Methods for making and using endoxifen
#6789DENDRIMER COMPOSITIONS AND METHODS FOR DRUG DELIVERY TO INJURED KIDNEY
#6790FIBRONECTIN EXTRA DOMAIN B (EDB) -SPECIFIC CAR-T FOR CANCER
#6791METHODS FOR TREATING DIGITALLY-IDENTIFIED IL-4/IL-13 RELATED DISORDERS
#6792Pharmaceutical Composition For Allergen Specific Immunotherapy
#6793METHODS FOR TREATING GRAFT-VERSUS-HOST DISEASE USING GLP-2 AGONISTS AND ANALOGUES THEREOF
#6794Cyclosporine formulations for use in the treatment of bronchiolitis obliterans syndrome (BOS)
#6795Small Molecule Cancer Treatments that Cause Necrosis in Cancer Cells But Do Not Affect Normal Cells
#6796METHODS AND COMPOSITIONS OF BIOCONTROL OF PLANT PATHOGENS
#6797TREATING OF NEUROLOGICAL DISORDERS USING EXTRACELLULAR VESICLES RELEASED BY HUMAN INDUCED PLURIPOTENT STEM CELL DERIVED NEURAL STEM CELLS
#6798METHOD FOR DIRECT REPROGRAMMING FROM SOMATIC CELLS INTO PANCREATIC BETA CELLS BY USING MICRORNA, AND DIFFERENTIATION COMPOSITION
#6799METHOD OF TARGETING ONCOLYTIC VIRUSES TO TUMORS
#6800CANCER THERAPY USING TOLL-LIKE RECEPTOR AGONISTS
#6801METHODS AND COMPOSITIONS FOR ATTENUATING ANTI-VIRAL TRANSFER VECTOR IMMUNE RESPONSES
#6802Methods for treating or preventing ophthalmological conditions
#6803METHODS FOR TREATING OR PREVENTING OPHTHALMOLOGICAL CONDITIONS
#6804BRAIN HEALTH SUPPLEMENTS
#6805METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS
#6806COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
#6807HSPC-SPARING TREATMENTS FOR RB-POSITIVE ABNORMAL CELLULAR PROLIFERATION
#6808TREATMENT OF CANCERS USING PI3 KINASE ISOFORM MODULATORS
#6809SOLID FORMS OF A TOLL-LIKE RECEPTOR MODULATOR
#6810Use of FAK inhibitor in preparation of drug for treating tumors having NRAS mutation
#6811THERAPEUTIC TARGETING OF ACTIVATED AVIL-INDUCED SARCOMAS
#6812MUSCARINIC ACETYLCHOLINE M1 RECEPTOR ANTAGONISTS
#6813Compounds and Compositions for Disrupting Programmed Ribosomal Frameshifting
#6814Topical roflumilast formulation having improved delivery and plasma half-life
#6815METHODS AND COMPOSITIONS FOR TREATING GLUCOCORTICOID EXCESS
#6816Methods of improving renal function
#6817Methods of Treating or Preventing Acute Respiratory Distress Syndrome
#6818C5 KETONE COMPOSITIONS AND RELATED METHODS FOR THERAPEUTIC AND PERFORMANCE SUPPLEMENTATION
#6819COMPOUNDS FOR TREATING VIRUS INFECTIONS
#6820TREATMENT OF BRAIN COPPER DISORDERS
#6821PARENTERAL TREATMENTS INVOLVING AMINOADAMANTANE DERIVATIVES
#6822Compositions Comprising (Bio)-Alkanediols with Antimicrobials for Product Protection
#6823PROCESS FOR PROVIDING PARTICLES WITH REDUCED ELECTROSTATIC CHARGES
#68243D PHARMACOPHORE MODEL FOR THE RAPID COMPUTATIONAL SCREENING OF SARS-COV-2 MODULATORS AND COMPOSITIONS AND METHODS THEREOF
#6825METHODS OF USING OX40 LIGAND ENCODING POLYNUCLEOTIDES
#6826OLIGONUCLEOTIDE TREATMENT OF HEPATITIS B PATIENTS
#6827METHOD AND AGENT FOR TREATING/PREVENTING NEURODEGENERATIVE DISEASE AND ASSOCIATED NEUROINFLAMMATION AND FOR EVALUATING PUTATIVE PROPHYLACTICS/THERAPEUTICS FOR TREATING/PREVENTING NEURODEGENERATIVE DISEASE AND NEUROINFLAMMATION
#6828PH20 polypeptide variants, formulations and uses thereof
#6829USE OF INHIBITORS OF ADAM12 AS ADJUVANTS IN TUMOR THERAPIES
#6830RNF167 AND CASTOR1 AS NOVEL MTOR TARGETS
#6831METHODS FOR TREATING SKIN INFECTION BY ADMINISTERING AN IL-4R ANTAGONIST
#6832CD47 BINDING AGENTS AND USES THEREOF
#6833ANTI-CLAUDIN18.2 AND CD3 BISPECIFIC ANTIBODY AND USE THEREOF
#6834IMMUNOTHERAPY
#6835USE OF ANTI-FAMILY WITH SEQUENCE SIMILARITY 19, MEMBER A5 ANTIBODIES FOR THE TREATMENT OF NEUROPATHIC PAIN
#6836Methods of altering bone growth by administration of Sost or Wise antagonist or agonist
#6837Antigen Binding Molecules Targeting SARS-CoV-2
#6838Antigen binding molecules targeting SARS-CoV-2
#6839Saponin derivatives with improved therapeutic window
#6840PROGESTERONE PHOSPHATE ANALOGS AND USES RELATED THERETO
#6841BIOACTIVE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF
#6842ANTIVIRAL HETEROCYCLIC COMPOUNDS
#6843AGONISTS OF STIMULATOR OF INTERFERON GENES STING
#6844HETEROARYL COMPOUNDS, PREPARATION METHODS AND USES THEREOF
#6845TETRAHYDROQUINAZOLINE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS
#6846Inhibitors of dihydroceramide desaturase for treating disease
#6847CFTR regulators and methods of use thereof
#6848COMPOSITIONS CONTAINING COATED MINERALS OR MINERAL-AMINO ACID COMPLEXES
#6849POPULATIONS OF NATURAL KILLER CELLS COMPRISING A CLEAVAGE RESISTANT CD16
#6850Immunomodulatory Compounds And Use Thereof For The Treatment And/Or Prevention Of Infectious Diseases
#6851COMPOSITIONS, METHODS AND USES FOR THERMALLY STABLE HUMAN PAPILLOMAVIRUS FORMULATIONS
#6852GLYCOCONJUGATION PROCESSES AND COMPOSITIONS
#6853PEPTIDE FOR THERAPEUTIC APPLICATIONS IN THE DERMATOLOGICAL FIELD
#6854VIMENTIN AND FRAGMENTS OR DERIVATIVES THEREOF FOR CORONAVIRUS TREATMENT AND PREVENTION
#6855COMPOSITIONS FOR INHIBITING VIRAL ENTRY AND METHODS USING SAME
#6856COMPOSITIONS CONTAINING KRATOM COMPOUNDS
#6857PARABACTEROIDES DISTASONIS STRAINS FOR USE THEREOF IN THE TREATMENT AND PREVENTION OF GASTROINTESTINAL DISEASES AND OF DISORDERS ASSOCIATED WITH GASTROINTESTINAL DISEASES
#6858AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE UROGENITAL SYSTEM
#6859METHOD FOR PREVENTING AND/OR TREATING HELICOBACTER PYLORI-RELATED DISEASE BY USING PARABACTEROIDES GOLDSTEINII AND ITS METABOLITES
#6860HIGHLY ACTIVE NK CELL AND USE THEREOF
#6861Upregulation of Cathelicidin Gene Expression as an Adjuvant to Other Treatments for Diseases
#6862Bi-functional co-polymer use for ophthalmic and other topical and local applications
#6863ACTIVE INGREDIENTS AND DRUGS FOR THE THERAPY OF VIRAL DISEASES, ESPECIALLY CORONA INFECTIONS, ESPECIALLY COVID-19
#6864TOPICAL COMPOSITIONS AND METHODS FOR TREATING PSORIASIS
#6865DEUTERATED PARAXANTHINE AND USES THEREOF
#6866DEUTERATED DERIVATIVES OF RUXOLITINIB
#6867INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
#6868METHODS OF TREATMENT
#6869METHODS OF CHEMOVACCINATION AGAINST PLASMODIUM INFECTIONS
#6870RAF INHIBITOR FOR TREATING LOW GRADE GLIOMA
#6871METHODS AND COMPOSITIONS FOR SLEEP DISORDERS AND OTHER DISORDERS
#6872METHODS FOR TREATING PANCREATIC DUCTAL ADENOCARCINOMA
#6873TOPOTECAN FOR PROLIFERATIVE VITREORETINOPATHY
#6874TREATMENT AND/OR PREVENTION OF A VIRAL INFECTION
#6875COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT AND PREVENTION OF AVIAN PATHOGENIC E. COLI (APEC)
#6876COMPOSITIONS AND METHODS OF USING NMDAR INHIBITORS AND KINASE INHIBITORS TO TREAT LIVER CANCER
#6877Methods of improving renal function
#6878METHODS OF REDUCING DISEASE FLARES
#6879TREATMENT OF AUTOIMMUNE DISEASE IN A PATIENT RECEIVING ADDITIONALLY A BETA-BLOCKER
#6880ANTIBIOTIC CANNABINOID-TERPENE FORMULATIONS
#6881Compositions comprising cannabinoids and methods of use
#6882HUNGER SUPPRESSION
#6883METHODS FOR STABILIZING ATHEROSCLEROTIC PLAQUES USING LIPOXINS, RESOLVINS, AND ANALOGS THEREOF
#6884N-ACETYLCYSTEINE ATTENUATES AORTIC STENOSIS PROGRESSION BY INHIBITING SHEAR-MEDIATED TGF-BETA ACTIVATION AND FIBROSIS
#6885MEDICAMENTS FOR SLOWING PARKINSON'S DISEASE
#6886SYSTEM AND METHOD OF DELIVERING INHIBITORS FOR PREVENTING THE ENTRY OF SARS-CoV-2 AND EMERGING VARIANTS
#6887Threonate Compounds and Methods of Use Thereof
#6888STABILIZATION OF VITAMIN A IN A NUTRITIONAL SOLUTION
#6889COMPOSITIONS FOR PREVENTING AND TREATING VIRAL INFECTIONS
#6890Pharmaceutical Composition Containing Elemene, Preparation Method Therefor, And Use Thereof
#6891STROKE TREATMENT
#6892LIPID-POLYMER COMPOSITIONS AND METHODS OF USE
#6893ORAL DELIVERY SYSTEMS BASED ON IN SITU FORMING PROTEIN/POLYSACCHARIDE COACERVATES
#6894Exosomal compositions and methods for the treatment of disease
#6895MICROEMULSION FOR THE TREATMENT OF DRY EYE SYNDROME
#6896DECELLULARIZED TISSUE-DERIVED EXTRACELLULAR MATRIX FUNCTIONALIZED WITH PHENOL DERIVATIVE AND USE THEREOF
#6897Rapamycin for the treatment of lymphangioleiomyomatosis
#6898BIODEGRADABLE POLYMER AND SOLVENT COMPOSITIONS AND SYSTEMS FOR EXTENDED STORAGE AND DELIVERY OF ACTIVE PHARMACEUTICAL INGREDIENTS
#6899COMPOSITIONS AND METHODS FOR RELIEVING PAIN
#6900COMPOSITIONS FOR REDUCING HAIR LOSS AND/OR INCREASING HAIR REGROWTH